Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • markusl
    Junior Member
    • Sep 2011
    • 2

    Illumina vs. Agilent Exome enrichment - higher false positive rates

    Hello,

    We are sequencing whole exomes (human) using an Illumina HiSeq2000. We previously did sample prep and exome enrichment using the Agilent SureSelect Human All Exon Kit. Recently we switched to the Illumina sample prep and exome enrichment kits, however we observed a dramatic increase in false positive SNP calls (the analysis pipeline is the same).

    Has anybody else compared Agilent and Illumina exome enrichments and observed similar problems?

    Thanks for any comments.

    markusl
  • Rocketknight
    Member
    • Sep 2011
    • 86

    #2
    Seconding this question! I'm in a lab that's just starting to get involved with whole exome sequencing, and I haven't been able to find any quality comparisons of the different exome capture methods. Any advice/experiences people have had with them would be awesome.

    Comment

    • stanford_genome_tech
      Junior Member
      • Aug 2009
      • 7

      #3
      Several major papers on this topic will be coming out shortly. Be on the lookout in Genome Biology as well as others for bakeoff studies.

      Comment

      • Heisman
        Senior Member
        • Dec 2010
        • 534

        #4
        If you are going to analyze multiple, unrelated exomes, you can simply filter out variants that appear in more than X % of the exomes. Granted, you won't get any information from those specific bases, so you have to consider if that is worthwhile (ie, if you are studying a rare Mendelian disease you will probably be fine; if you are studying other more common things and intend to do association tests of some sort then you probably don't want to filter out the common variants.

        Comment

        • markusl
          Junior Member
          • Sep 2011
          • 2

          #5
          Yes, analyzing multiple samples could help. However we also would be interested if the sample prep method from illumina is somewhat more errorprone compared to Agilent - in that case it would be better to stay with Agilent. Then we have less problems downstream.

          Thanks for any replies so far...

          markusl

          Comment

          • Michael.James.Clark
            Senior Member
            • Apr 2009
            • 207

            #6


            Ask and ye shall receive.

            In particular note the comparisons between exome-seq and WGS in the end. Not a substantially higher false positive rate in either.
            Last edited by Michael.James.Clark; 09-30-2011, 10:52 AM.
            Mendelian Disorder: A blogshare of random useful information for general public consumption. [Blog]
            Breakway: A Program to Identify Structural Variations in Genomic Data [Website] [Forum Post]
            Projects: U87MG whole genome sequence [Website] [Paper]

            Comment

            • Rocketknight
              Member
              • Sep 2011
              • 86

              #7
              I love when two papers get published on exactly the topic I need just as I decide I need to research it. Thanks to both of you!

              Comment

              • Rocketknight
                Member
                • Sep 2011
                • 86

                #8
                Quick question. I'm still trying to decide between the three exome capture methods. Am I right in thinking that the Illumina kit offers substantially higher throughput (assuming we don't have access to robotics, etc.) because it supports multiplexing before the enrichment protocol? Or is this also possible with the Agilent and Nimblegen kits?

                Comment

                • prathima
                  Junior Member
                  • Aug 2016
                  • 6

                  #9
                  I am sharing a publication link on Performance comparison of four exome capture systems for deep sequencing. This is might be useful as a very quick reference, I guess. Thanks to the authors.


                  https://bmcgenomics.biomedcentral.com/articles/10.1186/1471-2164-15-449


                  Please do share if any further useful information is available.

                  Comment

                  • Geneus
                    Member
                    • Dec 2010
                    • 60

                    #10
                    Originally posted by prathima View Post
                    I am sharing a publication link on Performance comparison of four exome capture systems for deep sequencing. This is might be useful as a very quick reference, I guess. Thanks to the authors.


                    https://bmcgenomics.biomedcentral.com/articles/10.1186/1471-2164-15-449


                    Please do share if any further useful information is available.
                    I've been hearing good things as of late about IDT's exome kit (not tested in the above comparison)...maybe someone might want to comment?

                    Comment

                    Latest Articles

                    Collapse

                    • mylaser
                      Reply to Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
                      by mylaser
                      Kheloyar – Everything You Need to Know About Kheloyaar Login and Kheoyar Id
                      If you are looking for an online gaming platform that offers a user-friendly experience, Kheloyar has become a name that many users search for. Whether you're interested in creating a new account, accessing your dashboard through Kheloyaar Login, or learning how to obtain a Kheoyar Id, understanding the platform's features and account process is essential.
                      This guide explains everything you need to know about...
                      Yesterday, 01:13 AM
                    • SEQadmin2
                      Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
                      by SEQadmin2



                      Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
                      ...
                      07-09-2026, 11:10 AM
                    • SEQadmin2
                      Cancer Drug Resistance: The Lingering Barrier to Rising Survival
                      by SEQadmin2



                      Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

                      There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
                      07-08-2026, 05:17 AM

                    ad_right_rmr

                    Collapse

                    News

                    Collapse

                    Topics Statistics Last Post
                    Started by SEQadmin2, 07-09-2026, 10:04 AM
                    0 responses
                    21 views
                    0 reactions
                    Last Post SEQadmin2  
                    Started by SEQadmin2, 07-08-2026, 10:08 AM
                    0 responses
                    13 views
                    0 reactions
                    Last Post SEQadmin2  
                    Started by SEQadmin2, 07-07-2026, 11:05 AM
                    0 responses
                    31 views
                    0 reactions
                    Last Post SEQadmin2  
                    Started by SEQadmin2, 07-02-2026, 11:08 AM
                    0 responses
                    31 views
                    0 reactions
                    Last Post SEQadmin2  
                    Working...